Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Holding HK:9989?
Track your performance easily
9989 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.39 - HK$5.92
Previous CloseN/A
Volume172.00K
Average Volume (3M)470.93K
Market Cap
HK$14.15B
Enterprise ValueHK$7.50B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Mar 27, 2025EPS Estimate
0.02Last Dividend Ex-Date
May 24, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding220,094,500
10 Day Avg. Volume379,100
30 Day Avg. Volume470,925
Standard Deviation0.09
R-Squared0.40
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)69.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H News
PremiumCompany Announcements
Hepalink Partners with Yongtai for U.S. Gabapentin Market
PremiumCompany Announcements
Shenzhen Hepalink Releases 2024 Q3 Financial ReportPremiumCompany Announcements
Shenzhen Hepalink Schedules Board Meeting for Q3 Results
PremiumCompany Announcements
Hepalink Announces Strong Mid-Year Financials
PremiumCompany Announcements
Shenzhen Hepalink Announces Upcoming Board Meeting
PremiumCompany Announcements
Shenzhen Hepalink Sees Soaring H1 2024 ProfitsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.36% Mutual Funds
― Other Institutional Investors
99.30% Public Companies and
Individual Investors
9989 FAQ
What was Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s price range in the past 12 months?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H lowest stock price was HK$2.39 and its highest was HK$5.92 in the past 12 months.
What is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s market cap?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s market cap is HK$14.15B.
When is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s upcoming earnings report date?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s upcoming earnings report date is Mar 27, 2025 which is in 66 days.
How were Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s earnings last quarter?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H released its earnings results on Oct 30, 2024. The company reported HK$0.087 earnings per share for the quarter, beating the consensus estimate of HK$0.077 by HK$0.01.
Is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H overvalued?
According to Wall Street analysts Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s price is currently Overvalued.
Does Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H pay dividends?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H pays a Thriceyearly dividend of HK$0.113 which represents an annual dividend yield of N/A. See more information on Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H dividends here
What is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s EPS estimate?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s EPS estimate is 0.02.
How many shares outstanding does Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H have?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H has 220,094,500 shares outstanding.
What happened to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s price movement after its last earnings report?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H reported an EPS of HK$0.087 in its last earnings report, beating expectations of HK$0.077. Following the earnings report the stock price went down -1.116%.
Which hedge fund is a major shareholder of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:9989
---
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.98%
12-Months-Change
Fundamentals
Return on Equity
-1.17%
Trailing 12-Months
Asset Growth
-7.01%
Trailing 12-Months
Company Description
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
Shoe Zone PLC operates as a footwear retailer offering a wide range and a variety of shoes for all ages, it functions with over 500 stores across the UK. The group has a single distribution center which is located in Leicester, England. Its online offering combined with its store portfolio allows customers to shop via multiple channels. Shoe zone and its subsidiaries operate in the United Kingdom and the Republic of Ireland. The majority of the revenue is generated from the United Kingdom.
---
Technical Analysis
---